Jenburkt Pharmaceuticals Limited — Quarter and year ended 31st March, 2026
| Particulars | Quarter Ended 31-03-2026 (Audited) | Quarter Ended 31-03-2025 (Audited) | Year Ended 31-03-2026 (Audited) | Year Ended 31-03-2025 (Audited) |
|---|---|---|---|---|
| I Revenue from Operations | 4463.23 | 4104.69 | 16874.06 | 15169.15 |
| II Other Income | 434.83 | 188.02 | 1029.94 | 672.10 |
| III Total income (I + II) | 4898.06 | 4292.71 | 17904.00 | 15841.25 |
| IV Expenses | ||||
| (a) Cost of Materials Consumed | 219.35 | 228.48 | 899.35 | 851.12 |
| (b) Purchase of Stock-in-trade | 869.61 | 524.61 | 2817.89 | 2126.08 |
| (c) Changes in inventories of Finished Goods, Stock-in-trade and WIP | -222.68 | 37.16 | -484.67 | -11.55 |
| (d) Employee benefit expenses | 951.53 | 1143.35 | 4988.22 | 4553.58 |
| (e) Finance Costs | 12.92 | 11.13 | 46.20 | 45.28 |
| (f) Depreciation and Amortisation Expense | 80.88 | 79.13 | 310.76 | 272.79 |
| (g) Other expenses | 1220.52 | 1085.31 | 4279.25 | 3610.67 |
| Total Expenses (IV) | 3132.13 | 3109.17 | 12857.00 | 11447.97 |
| V Profit before exceptional items and tax (III-IV) | 1765.93 | 1183.54 | 5047.00 | 4393.28 |
| VI Exceptional items | ||||
| Impact of Labour Codes # | 395.11 | 0.00 | 395.11 | 0.00 |
| VII Profit before tax (V-VI) | 1370.82 | 1183.54 | 4651.89 | 4393.28 |
| VIII Tax Expense | ||||
| (i) Current Tax | 360.00 | 340.00 | 1260.00 | 1190.00 |
| (ii) Income Tax for previous years | 4.10 | 17.80 | 4.10 | 17.80 |
| (iii) Deferred Tax | -78.23 | -27.92 | -85.81 | -20.58 |
| IX Profit/(Loss) after Tax (VII-VIII) | 1084.95 | 853.66 | 3473.60 | 3206.06 |
| X Other Comprehensive Income | ||||
| A A (i) Items that will not be reclassified to profit or loss | -347.92 | -49.98 | -171.20 | 136.06 |
| (ii) Income Tax relating to Items that will not be reclassified to profit or loss | 26.51 | 4.83 | 18.30 | 16.80 |
| B B (i) Items that will be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 |
| (ii) Income Tax relating to Items that will be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 |
| XI Total Comprehensive Income for the period (IX+X) | 763.54 | 808.51 | 3320.70 | 3358.92 |
| Paid up Equity Share Capital (F.V. Rs.10/- each) | 441.33 | 441.33 | 441.33 | 441.33 |
| XII Earnings Per Share (in Rs.) (F.V. Rs.10/-) Basic and Diluted | 24.58 | 19.34 | 78.71 | 72.65 |
| Particulars | Note | 31/03/2026 Amount | 31/03/2025 Amount |
|---|---|---|---|
| ASSETS | |||
| (1) Non-current Assets | |||
| (a) Property, Plants & Equipments | 1 | 1130.41 | 1229.47 |
| (b) Right to Use Asset | 2 | 791.63 | 213.44 |
| (c) Other Intangible assets | 2 | 24.14 | 22.79 |
| (d) Capital Work In Progress | 3 | 4611.93 | 4027.67 |
| (e) Financial Assets | |||
| (i) Investments | 4 | 2702.37 | 2055.81 |
| (ii) Loans | 5 | 0.70 | 1.90 |
| (iii) Other Financial Assets | 6 | 3466.07 | 5990.89 |
| Deferred Tax Asset | 7 | 239.90 | 146.93 |
| (f) Other Non-current Assets | 8 | 125.16 | 276.54 |
| (2) Current assets | |||
| (a) Inventories | 9 | 1363.31 | 888.03 |
| (b) Financial Assets | |||
| (i) Trade Receivables | 10 | 2435.69 | 2073.49 |
| (ii) Cash and Cash Equivalents | 11 | 557.71 | 736.48 |
| (iii) Bank Balance other than (iii) | 12 | 4753.74 | 1728.11 |
| (iv) Loans | 13 | 6.34 | 5.20 |
| (v) Other Financial Assets | 14 | 39.80 | 40.30 |
| (c) Other Current Assets | 15 | 336.53 | 165.73 |
| Current Tax Asset (Net) | 16 | 15.81 | 15.81 |
| Total Assets | 22,601.26 | 19,618.60 | |
| EQUITY AND LIABILITIES | |||
| (1) Equity | |||
| (a) Equity Share Capital | 17 | 441.33 | 441.33 |
| (b) Other Equity – Reserves & Surplus | 18 | 19,262.69 | 16,736.38 |
| Liabilities | |||
| (2) Non-current liabilities | |||
| (a) Financial Liabilities | |||
| (i) Lease Liabilities | 19 | 183.95 | 149.19 |
| (ii) Other Financial Liabilities | 20 | 301.03 | 301.03 |
| (b) Deferred Tax Liability | 7 | 97.59 | 108.74 |
| (3) Current Liabilities | |||
| (a) Financial Liabilities | |||
| (i) Lease Liabilities | 21 | 64.87 | 42.31 |
| (ii) Borrowings | 22 | – | 197.88 |
| (iii) Trade Payables | |||
| (A) Total Outstanding dues of Micro Enterprises and Small Enterprises; and | 23 | 27.48 | 16.56 |
| (B) Total Outstanding dues of creditors other than Micro Enterprises and Small Enterprises. | 23 | 782.47 | 798.97 |
| (iv) Other Financial Liabilities | 24 | 539.83 | 467.93 |
| (b) Other Current Liabilities | 25 | 126.96 | 169.29 |
| (c) Provisions # | 26 | 659.26 | 160.40 |
| (d) Current Tax Liabilities (Net) | 16 | 113.80 | 28.59 |
| Total Equity and Liabilities | 22,601.26 | 19,618.60 |
| # | Description | 31-03-2026 | 31-03-2025 |
|---|---|---|---|
| A. CASH FLOW FROM OPERATING ACTIVITIES : | |||
| a | Net Profit After Tax | 3,473.60 | 3,206.06 |
| Adjustments for : | |||
| i | Depreciation and Amortisation Expense | 310.77 | 272.79 |
| ii | Loss on Fixed Assets scrapped | 4.52 | 3.39 |
| iii | Tax Expense | 1,178.29 | 1,187.22 |
| iv | Finance Cost | 46.20 | 45.28 |
| v | Interest Income | (558.88) | (526.22) |
| vi | Dividend income | (15.77) | (8.73) |
| vii | Unrealised Gain on Investment at Fair Value | (15.12) | (5.17) |
| viii | Gain on sale of investment (Short Term Capital Gain / Loss) | (37.46) | (80.59) |
| ix | Provision/write off for doubtful trade receivables/advances | (186.77) | 7.92 |
| x | Unrealised Foreign Exchange gain | (71.08) | (19.36) |
| xi | Others | 1.97 | 1.92 |
| Operating profit (Loss) before working capital changes | 4,130.27 | 4,084.49 | |
| b | MOVEMENTS IN WORKING CAPITAL | ||
| i | Increase or (Decrease) in Inventories | (475.29) | (31.86) |
| ii | Increase or (Decrease) in Trade Receivables | (104.35) | (114.53) |
| iii | Increase or (Decrease) in Other (Current & Non Current) Assets | 70.23 | (141.33) |
| iv | Increase or (Decrease) in Trade Payables | (5.58) | 189.81 |
| v | Increase or (Decrease) in Bank Borrowings | (197.88) | 197.88 |
| vi | Increase or (Decrease) in Other (Current & Non Current) Liabilities | 29.19 | (114.30) |
| vii | Current & Non Current Financial Loans | 0.06 | 4.99 |
| viii | Increase or (Decrease) in Provisions | 384.43 | 58.74 |
| c | Cash used in operation | 3,831.07 | 4,133.91 |
| i | Income Taxes paid (Net of Refund) | (1,178.89) | (1,343.31) |
| Net cash used in operating activities (A) | 2,652.18 | 2,790.60 | |
| B. CASH FLOW FROM INVESTING ACTIVITIES : | |||
| i | Payments for purchase of Property, Plant and Equipment (Including Capital Work in Progress, Intangible Assets and Intangible Assets in Development) | (1,371.71) | (1,971.36) |
| ii | Proceeds from disposal of property, plant and equipment and intangible assets | 0.82 | – |
| iii | Purchase of Investments | (3,912.20) | (3,762.77) |
| iv | Proceeds from Sale / Redemption of Investments | 3,261.43 | 3,616.29 |
| Other Bank balances not considered as cash and cash equivalents | |||
| – Bank Fixed Deposit made during the year | (11,045.37) | (15,287.38) | |
| – Bank Fixed Deposit matured during the year | 10,944.41 | 15,155.72 | |
| v | Interest Received | 161.82 | 536.30 |
| vi | Dividend Received | 15.77 | 8.73 |
| Net cash generated by investing activities (B) | (1,945.03) | (1,704.47) | |
| C. CASH FLOW FROM FINANCING ACTIVITIES : | |||
| i | Finance Cost | (27.98) | (28.04) |
| ii | Dividend paid | (793.94) | (678.05) |
| iii | Repayment of Lease Liabilities | (63.99) | (56.10) |
| Net cash used in financing activities (C) | (885.92) | (762.19) | |
| NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENT (A+B+C) | (178.77) | 323.94 | |
| Cash and cash equivalent at the beginning of the year (1st April, 2025) | 736.48 | 412.54 | |
| Cash and cash equivalent as at the end of the year (31st March, 2026) | 557.71 | 736.48 | |
| (178.77) | 323.94 |